Align’s Swiss Oral Health Study Puts Digital Tools And Growth Story To Test
Align’s Swiss Oral Health Study Puts Digital Tools And Growth Story To Test
Publish Date: 2026-02-13 04:36:00
Source Domain: simplywall.st
- Align Technology is partnering with the University of Bern on Switzerland’s first comprehensive Swiss Oral Health Study.
- The project uses Align’s iTero Lumina digital scanners and mobile dental vans to collect real time oral health data across the country.
- The collaboration focuses on preventive care insights and broader public health impact beyond Align’s core orthodontic products.
For investors watching NasdaqGS:ALGN, this research tie up sits alongside a share price of $183.86 and mixed recent performance. The stock is up 4.7% over the past week and 8.0% over the past month, but shows a 10.3% decline over the past year. Longer term returns have been weaker, with 3 year and 5 year returns of 43.6% and 69.1% declines, so developments outside quarterly numbers can matter for how the story is framed.
This Swiss Oral Health Study places Align in the middle of a public health project that could expand how its scanners and digital tools are used in real world settings. As results emerge and the project scales, investors may watch whether this type of collaboration supports adoption of Align’s technology across more clinics and public health programs.
Stay updated on the most important news stories for Align Technology by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Align Technology.
NasdaqGS:ALGN Earnings & Revenue Growth as at Feb 2026
We’ve flagged 0 risks for Align Technology. See which could impact your investment.
For Align, this Swiss Oral Health Study sits neatly alongside its iTero Lumina scanner rollout and recent financial updates. The company just reported fourth quarter 2025 sales of US$1,047.56 million and net income of US$135.76 million, with full year 2025 sales of US$4,034.96 million and net income of US$410.35 million. Management is guiding for 2026 worldwide revenue growth of 3% to 4%, and has been active on capital returns, repurchasing 1,223,203 shares for US$171.57 million under…
